Is SAB Biotherapeutics, Inc. technically bullish or bearish?

Sep 20 2025 08:17 PM IST
share
Share Via
As of September 11, 2025, SAB Biotherapeutics shows a mildly bullish technical trend supported by strong weekly indicators, despite mixed signals in the longer term and underperformance year-to-date.
As of 11 September 2025, the technical trend has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, and the Bollinger Bands are bullish on both weekly and monthly time frames, supporting the bullish stance. However, the weekly RSI is bearish, indicating some weakness. The moving averages are bullish on the daily timeframe, while the KST is bullish weekly and mildly bullish monthly. Dow Theory shows a mildly bullish weekly trend but bearish monthly, and the OBV is mildly bullish weekly and mildly bearish monthly.

In terms of multi-period returns, SAB Biotherapeutics has outperformed the S&P 500 over the past week and month, with returns of 31.6% and 27.98% respectively, while it has underperformed year-to-date and over the past year. Overall, the current technical stance is mildly bullish, driven by strong weekly indicators despite some mixed signals in the longer term.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is SAB Biotherapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:28 AM IST
share
Share Via
What does SAB Biotherapeutics, Inc. do?
Jun 22 2025 07:12 PM IST
share
Share Via
How big is SAB Biotherapeutics, Inc.?
Jun 22 2025 06:23 PM IST
share
Share Via